Navigation Links
HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication
Date:12/28/2010

s, whether as a result of new information, future events or otherwise.  HeartWare may not actually achieve the plans, projections or expectations disclosed in forward-looking statements, and actual results, developments or events could differ materially from those disclosed in the forward-looking statements.  Forward-looking statements are subject to a number of risks and uncertainties, including without limitation, the possibility the FDA does not accept our PMA application or approve the marketing of the HeartWare® Ventricular Assist System in the U.S., and those described in "Item 1A. Risk Factors" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission.  We may update our risk factors from time to time in "Part II, Item 1A "Risk Factors" in our Quarterly Reports on Form 10-Q, or other current reports, as filed with the Securities and Exchange Commission.For further information:Christopher TaylorHeartWare International, Inc.Email: ctaylor@heartwareinc.comPhone: +1 508 739 0864
'/>"/>
SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HeartWare International, Inc. Announces Completion of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
2. HeartWare International, Inc. Announces Pricing of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
3. HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock
4. HeartWare to Present at the Canaccord Genuity Cardio/Diabetes & Obesity Conference
5. HeartWare Achieves Primary Endpoint with 92% Success in Pivotal Bridge-to-Transplant Clinical Trial, ADVANCE
6. HeartWare to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
7. HeartWare Bridge-to-Transplant Data Featured as Late Breaking Clinical Trial at American Heart Association Scientific Sessions 2010
8. HeartWare International Reports Third Quarter 2010 Revenues of $13.8 Million; Compared to $7.5 Million in Third Quarter of 2009
9. HeartWare to Report Financial Results for Third Quarter of 2010
10. HeartWare to Present at Lazard Capital Markets Circulatory Assist Device Day
11. HeartWare to Present at the UBS 2010 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... June 29, 2015 Research ... the "Pharmaceutical Grade Sodium Chloride Market by Applications, ... report to their offering. The pharmaceutical ... CAGR of 6.9% between 2014 and 2019 in terms ... 690 KT by 2019. The report on ...
(Date:7/6/2015)... 6, 2015 Moerae Matrix, a clinical ... that target inflammation and fibrosis, today announced the ... as Chief Medical Officer. Dr. ... and programs, which include a pipeline of therapies ... conditions.  Bill is an accomplished strategist and scientist ...
(Date:7/6/2015)... 2015 Celtaxsys, Inc., a clinical stage pharmaceutical ... rare and orphan inflammatory disease indications, announced today that ... Drug Administration (FDA) to begin a Phase 2 clinical ... adult CF patients in the US. The regulatory submissions ... will be filed soon after. This groundbreaking clinical ...
Breaking Medicine Technology:Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... N.C. , June 21 Gentris Corporation ... pharmacogenomics, announced today that Rick Williams has ... member of the Board of Directors.  In his role ... company,s scientific leadership continues to provide biotechnology and pharmaceutical ...
... LONDON , June 21 Thomson Reuters announced ... innovative resource designed to change the way biotechnology, pharmaceutical and academic ... , , ... available free to all organizations with drugs in development. It enables ...
Cached Medicine Technology:Gentris Corporation Names New Chief Executive Officer 2Gentris Corporation Names New Chief Executive Officer 3Gentris Corporation Names New Chief Executive Officer 4Thomson Reuters Creates The Outpartnering Registry, a Free Resource to Improve Drug Development Partnering 2Thomson Reuters Creates The Outpartnering Registry, a Free Resource to Improve Drug Development Partnering 3
(Date:7/6/2015)... ... July 06, 2015 , ... With a new community program ... up with Family Emergency Shelter Coalition (FESCO) and announced a new charity campaign ... especially to provide emergency services and support for homeless families, all the while ...
(Date:7/6/2015)... ... ... With a new community program in the Livonia, Canton and Plymouth areas, ... new charity campaign to raise funds in support of the health and safety of ... Youth is a coalition created especially to educate and empower teens, bringing awareness to ...
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is ... area patients. Kybella is a non-surgical method to dissolve fat cells and ... moderate to severe fat deposits under the chin, commonly known as a double chin. ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of us and the ... Americans have diabetes, the majority of which are Type 2. However, eight million do ... one in three, have prediabetes (abnormally high blood sugar levels). Without reductions in blood ...
(Date:7/5/2015)... Minneapolis, MN (PRWEB) , ... July 06, 2015 ... ... in the ancillary benefits market, is excited to announce the next generation of ... Plus and Advantage plans to now include two network options—Maximum Allowable Charge (MAC) ...
Breaking Medicine News(10 mins):Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... RICHMOND, Va., July 27 Insmed Inc. (Nasdaq: ... the Company will cease the supply of IPLEX((TM)) to any new ... trials with IPLEX((TM)) at this time. The Company has determined ... treatment of existing patients. , , ...
... , , ... will hold three (3) rallies this week to urge Congress to pass ... is being stalled because of partisanship and political infighting, the campaign seeks ... suffer daily because of escalating health care costs and sub-standard medical care. ...
... , , , ... (Nasdaq: SNSS ) today announced that Helen S. Kim ... Ms. Kim is a designee of New Enterprise Associates, which purchased ... of the company,s recent private placement. , , ...
... Emerging Therapies to Treat Metastatic Hormone-Refractory Prostate Cancer Will ... New Report from Decision Resources , , ... of the world,s leading research and advisory firms for pharmaceutical ... prostate cancer drug market though 2018 will be driven principally ...
... DENVER, July 27 Because nearly everyone struggles with medical bills, medical ... some tips on how you can best use and pay for your ... most respected companies of its type. These tips are from Andrew Graham, ... Your doctor will be more helpful to you if you are ...
... SynCare, LLC(R), an innovator in disease and case management, has been ... n a C o mp a n ... h . The 50 Companies to Watch program, created and managed by ... Small Business Development Center network and Purdue University. , , The ...
Cached Medicine News:Health News:Insmed Provides Update on Supply of IPLEX(TM) 2Health News:Insmed Provides Update on Supply of IPLEX(TM) 3Health News:Delaying Health Care Reform is U-N-A-C-C-E-P-T-A-B-L-E! 2Health News:Sunesis Pharmaceuticals Appoints Helen S. Kim to Board of Directors 2Health News:Driven by Launch of Emerging Therapies, Overall Prostate Cancer Drug Market Will Increase by $2 Billion Through 2018 2Health News:Driven by Launch of Emerging Therapies, Overall Prostate Cancer Drug Market Will Increase by $2 Billion Through 2018 3Health News:What the Medical Biller Knows (That You Should Know) 2Health News:SynCare, LLC Honored as Indiana Company to Watch 2
Occluder and Maddox Rod...
Maddox Rod, long handle...
... The Snellen chart remains to ... A range of different optotypes can ... British, sheridan-gardner, landolt Cs, tumbling Es ... or column can be shown and ...
Snellen 10' Eye Test Chart....
Medicine Products: